CompaniesCornerstone BioPharma

Cornerstone BioPharma

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

127

By Phase

PHASE1/PHASE2: 2PHASE2: 1PHASE1: 1

By Status

TERMINATED: 3COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
NCT02340208
NCT02309892
NCT04203641
Hover over trial bars to see details

Recent Trials

NCT04203641Lead Sponsor
L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer
PHASE1/PHASE2Terminated
28 participants
Started: Dec 11, 2019 · Completed: Oct 24, 2024
NCT03891173Lead Sponsor
A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma
PHASE2Terminated
9 participants
Started: Feb 19, 2019 · Completed: May 22, 2020
NCT02309892Lead Sponsor
A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC
PHASE1Terminated
14 participants
Started: Apr 20, 2015 · Completed: Sep 20, 2019
NCT02340208Lead Sponsor
A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47
PHASE1/PHASE2Completed
76 participants
Started: May 31, 2012 · Completed: Dec 20, 2017